K. Lau

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

P. Smolak, R. Levin, R. Martin, 2017, Lupus.

Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis

V. Mok, J. Abrigo, A. Wong, 2017, Multiple sclerosis journal - experimental, translational and clinical.

A randomised controlled study comparing the efficacy of once-daily triple therapy with twice-daily triple therapy in the eradication of Helicobacter pylori

K. Lau, S. Lam, B. Wong, 1999 .

Prospective observational study of isoflavone and the risk of stroke recurrence: Potential clinical implications beyond vascular function

C. Lau, C. Siu, T. Lam, 2012, The journal of nutrition, health & aging.